Moderna Accrued Contingent Liabilities increased by 497.5% to $950.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests higher legal or operational risk, while a decrease may indicate the resolution of past uncertainties.
This represents the estimated financial obligations arising from past events where the outcome is uncertain but probable...
Peers typically disclose these in legal contingencies footnotes; high levels relative to equity can signal significant litigation exposure.
accrued_contingent_liabilities| Q1 '22 | Q1 '26 | |
|---|---|---|
| Value | $159.00M | $950.00M |
| QoQ Change | — | +497.5% |